Alterola Biotech, Inc. (ABTI)

OTCMKTS · Delayed Price · Currency is USD
0.0051
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
41.67%
Market Cap 7.55M
Revenue (ttm) n/a
Net Income (ttm) -2.78M
Shares Out 1.48B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20
Average Volume 41,949
Open 0.2000
Previous Close 0.0051
Day's Range 0.0051 - 0.2000
52-Week Range 0.0002 - 0.2000
Beta 72.84
RSI 48.50
Earnings Date Nov 21, 2025

About Alterola Biotech

Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom. [Read more]

Sector Healthcare
CEO David Hitchcock
Country United States
Stock Exchange OTCMKTS
Ticker Symbol ABTI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.